Paragon 28, Inc. Circular External Fixation System Cleared by FDA
Paragon 28, Inc. (FNA)
Company Research
Source: Business Wire
ENGLEWOOD, Colo.--(BUSINESS WIRE)--Paragon 28, Inc. (NYSE: FNA) (“PARAGON”), a leading medical device company exclusively focused on the foot and ankle orthopedic market, today announced today that the U.S. Food and Drug Administration (FDA) has given 501(k) marketing clearance to its Circular External Fixation System. The Circular External Fixation System, expected to commercially launch in early 2022, will complement Paragon 28’s comprehensive internal fixation portfolio and further expands Paragon 28’s product offering in the foot and ankle space.Brendan Shook, Paragon 28's Executive Vice President of Marketing commented, "We are excited to receive FDA clearance for P28’s first external fixation product offering. We believe it will be a nice complement to our existing product portfolio, and will further P28’s mission to improve foot and ankle patient outcomes. We look forward to the product line launching in the first half of 2022."About Paragon 28, Inc.Based in Englewood, Colo
Show less
Read more
Impact Snapshot
Event Time:
FNA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
FNA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
FNA alerts
High impacting Paragon 28, Inc. news events
Weekly update
A roundup of the hottest topics
FNA
News
- Paragon 28, Inc. (NYSE:FNA) has caught the attention of institutional investors who hold a sizeable 36% stake [Yahoo! Finance]Yahoo! Finance
- Paragon 28, Inc. (NYSE: FNA) had its "overweight" rating re-affirmed by analysts at Stephens. They now have a $18.00 price target on the stock.MarketBeat
- Appointment of Stephen M. Deitsch as new Chief Financial Officer [Yahoo! Finance]Yahoo! Finance
- Paragon 28, Inc. (NYSE: FNA) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $17.00 price target on the stock.MarketBeat
- Paragon 28 gives prelim Q1 numbers, announces CFO transition [Seeking Alpha]Seeking Alpha
FNA
Sec Filings
- 4/5/24 - Form DEFA14A
- 4/5/24 - Form DEF
- 4/4/24 - Form 8-K
- FNA's page on the SEC website